By Amirah Al Idrus
Among the many things we took for granted before COVID-19 were in-person gatherings, where everyone in biopharma could catch up, talk shop and maybe emerge with a new partner or two. Sanofi isn’t sweating it, though—the sudden need to go virtual gave companies a chance to get out of their dealmaking comfort zone.
read more
By Robert King
Pharmacy chains CVS Health and Walgreens reached a deal with the Trump administration to distribute COVID-19 vaccines directly to nursing homes at no out-of-pocket charge.
read more
By Angus Liu
Pfizer CEO Albert Bourla recently suggested the company would know whether its BioNTech-shared COVID-19 vaccine works by October. Criticism ensued. Now finding himself alone in the biopharma world with that bullish estimate, the Big Pharma chief is changing his tone.
read more
By Kyle Blankenship
In a tumultuous 2020, the COVID-19 pandemic and simmering racial protests have exposed gaps between the ideal America some of its citizens see and the real America on the ground. Few voices have captured that difference more clearly than Merck CEO Ken Frazier—and now Frazier is calling on corporate America to take a stand.
read more
By Paige Minemyer
Millennials' health is on the decline, due in large part to rising rates of several behavioral health conditions, according to a new report.
read more
By Angus Liu
The search for effective COVID-19 drugs presses on as the National Institutes of Health launches a new trial of three immune modulator drugs in hospitalized patients. The new phase 3 study will include Johnson & Johnson’s Remicade, Bristol Myers Squibb’s arthritis med Orencia and AbbVie's experimental ceniciviroc alongside Gilead's remdesivir.
read more
By Conor Hale
Beckman Coulter was awarded a contract from the U.S. Biomedical Advanced Research and Development Authority to develop a rapid diagnostic test for children that have a rare but serious reaction to the virus that causes COVID-19.
read more
By Healthcare Staff
Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.
read more
By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner
The NIH picked drugs from J&J, BMS and AbbVie for a phase 3 trial in hospitalized patients. Russia approved remdesivir to treat COVID-19. Sanofi's partnership exec isn't sweating the lack of in-person meetings during the pandemic. Beckman Coulter is developing a childhood COVID-19 test, and Cue Health won a DOD contract to scale diagnostic production.
read more
